During the past decade, CIPADI - Centro Integral de Prevencion y Atencion en Diabetes conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CIPADI - Centro Integral de Prevencion y Atencion en Diabetes" are "Type 2 Diabetes" (3 trials), "Cardiovascular Disease" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "CIPADI - Centro Integral de Prevencion y Atencion en Diabetes" in a lesser frequency.

Most popular intervention types in "CIPADI - Centro Integral de Prevencion y Atencion en Diabetes" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (5 trials), "Insulin Degludec" (3 trials), "Placebo" (3 trials), "Insulin Efsitora Alfa" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "CIPADI - Centro Integral de Prevencion y Atencion en Diabetes" are 10 trials for "All" genders.

Currently, there are NaN active trials in "CIPADI - Centro Integral de Prevencion y Atencion en Diabetes". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CIPADI - Centro Integral de Prevencion y Atencion en Diabetes, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CIPADI - Centro Integral de Prevencion y Atencion en Diabetes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".